DK1382348T3 - Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom - Google Patents

Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom

Info

Publication number: DK1382348T3
Authority: DK; Denmark
Prior art keywords: treatment; respiratory disease; vaccine formulation; bovine respiratory; polynucleotide vaccine
Prior art date: 1996-07-19

Application number

DK03016996T

Other languages

Danish (da)

English (en)

Inventor

Jean-Christophe Audonnet

Annabelle Bouchardon

Philippe Baudu

Michel Riviere

Original Assignee

Merial Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-19

Filing date

1997-07-16

Publication date

2006-03-13

1997-07-16 Application filed by Merial Sas filed Critical Merial Sas

2006-03-13 Application granted granted Critical

2006-03-13 Publication of DK1382348T3 publication Critical patent/DK1382348T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/813—Viral vaccine for bovine species, e.g. cattle

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK03016996T 1996-07-19 1997-07-16 Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom DK1382348T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9609403A FR2751229B1 (fr)	1996-07-19	1996-07-19	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
EP97934578A EP0912194B1 (fr)	1996-07-19	1997-07-16	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins

Publications (1)

Publication Number	Publication Date
DK1382348T3 true DK1382348T3 (da)	2006-03-13

Family

ID=9494497

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK03016996T DK1382348T3 (da)	1996-07-19	1997-07-16	Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom
DK97934578T DK0912194T3 (da)	1996-07-19	1997-07-16	Polynucleotid-vaccineformulering, især til behandling af respiratorisk sygdom hos kvæg

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK97934578T DK0912194T3 (da)	1996-07-19	1997-07-16	Polynucleotid-vaccineformulering, især til behandling af respiratorisk sygdom hos kvæg

Country Status (29)

Country	Link
US (2)	US6376473B1 (2)
EP (2)	EP1382348B1 (2)
JP (1)	JP2000516200A (2)
AP (1)	AP9701044A0 (2)
AR (1)	AR007862A1 (2)
AT (2)	ATE253376T1 (2)
AU (1)	AU734442B2 (2)
BR (1)	BR9710506A (2)
CA (1)	CA2260855C (2)
CO (1)	CO4700306A1 (2)
CZ (2)	CZ298915B6 (2)
DE (2)	DE69734483T2 (2)
DK (2)	DK1382348T3 (2)
ES (2)	ES2254833T3 (2)
FR (1)	FR2751229B1 (2)
HR (1)	HRP970383A2 (2)
HU (2)	HU225169B1 (2)
ID (1)	ID19513A (2)
IL (2)	IL127703A0 (2)
MA (1)	MA24269A1 (2)
NZ (4)	NZ508940A (2)
PE (1)	PE84699A1 (2)
PL (1)	PL190122B1 (2)
PT (1)	PT912194E (2)
PY (1)	PY970078A (2)
RU (1)	RU2305560C2 (2)
UA (1)	UA70914C2 (2)
WO (1)	WO1998003200A2 (2)
ZA (1)	ZA976283B (2)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2751229B1 (fr) *	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
US20040002472A1 (en) *	2000-01-21	2004-01-01	Audonnet Jean-Christophe Francis	Vaccination or immunization using a prime-boost regimen
US6852705B2 (en) *	2000-01-21	2005-02-08	Merial	DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en)	2000-01-21	2006-07-18	Merial	DNA vaccines for farm animals, in particular bovines and porcines
FR2804028B1 (fr) *	2000-01-21	2004-06-04	Merial Sas	Vaccins adn ameliores pour animaux de rente
US7906311B2 (en)	2002-03-20	2011-03-15	Merial Limited	Cotton rat lung cells for virus culture
EP1606419A1 (en)	2003-03-18	2005-12-21	Quantum Genetics Ireland Limited	Systems and methods for improving protein and milk production of dairy herds
US7468273B2 (en)	2003-05-01	2008-12-23	Meial Limited	Canine GHRH gene, polypeptides and methods of use
WO2005049794A2 (en)	2003-11-13	2005-06-02	University Of Georgia Research Foundation, Inc.	Methods of characterizing infectious bursal disease virus
WO2005112544A2 (en)	2004-02-19	2005-12-01	The Governors Of The University Of Alberta	Leptin promoter polymorphisms and uses thereof
RS51324B (sr)	2005-04-25	2010-12-31	Merial Ltd.	Vakcine protiv nipah virusa
US20080241184A1 (en)	2005-08-25	2008-10-02	Jules Maarten Minke	Canine influenza vaccines
US7771995B2 (en)	2005-11-14	2010-08-10	Merial Limited	Plasmid encoding human BMP-7
EP3147296A1 (en)	2005-11-14	2017-03-29	Merial, Inc.	Gene therapy for renal failure
US7862821B2 (en)	2006-06-01	2011-01-04	Merial Limited	Recombinant vaccine against bluetongue virus
US20080274137A1 (en) *	2007-05-02	2008-11-06	Jean Christophe Francis Audonnet	DNA plasmids having improved expression and stability
UA100692C2 (ru)	2007-05-02	2013-01-25	Мериал Лимитед	Днк-плазмиды, имеющие повышенную экспрессию и стабильность
EP3542815A1 (en)	2008-11-28	2019-09-25	Boehringer Ingelheim Animal Health USA Inc.	Recombinant avian influenza vaccine and uses thereof
EP2414386B1 (en)	2009-04-03	2016-01-27	Merial Limited	Newcastle disease virus vectored avian vaccines
US10633667B2 (en)	2009-12-28	2020-04-28	Boehringer Ingelheim Animal Health USA Inc.	Recombinant NDV antigen and uses thereof
SG10201503351RA (en)	2010-01-19	2015-06-29	Harvard College	Engineered Opsonin for Pathogen Detection and Treatment
US20130197612A1 (en)	2010-02-26	2013-08-01	Jack W. Lasersohn	Electromagnetic Radiation Therapy
ES2617743T3 (es)	2010-03-12	2017-06-19	Merial, Inc.	Vacunas recombinantes del virus de la lengua azul y sus utilizaciones
EP2611460B1 (en)	2010-08-31	2016-10-05	Merial, Inc.	Newcastle disease virus vectored herpesvirus vaccines
AR084358A1 (es) *	2010-12-27	2013-05-08	Lilly Co Eli	Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
WO2012090073A2 (en)	2010-12-30	2012-07-05	The Netherlands Cancer Institute	Methods and compositions for predicting chemotherapy sensitivity
US20140296248A1 (en)	2011-04-04	2014-10-02	Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis	Methods and compositions for predicting resistance to anticancer treatment
EP2694678A2 (en)	2011-04-04	2014-02-12	Netherland Cancer Institute	Methods and compositions for predicting resistance to anticancer treatment
US9216213B2 (en)	2011-04-20	2015-12-22	Merial, Inc.	Adjuvanted rabies vaccine with improved viscosity profile
WO2012149038A1 (en)	2011-04-25	2012-11-01	Advanced Bioscience Laboratories, Inc.	Truncated hiv envelope proteins (env), methods and compositions related thereto
CA2837582C (en)	2011-05-27	2021-03-02	Merial Limited	Genetic vaccines against hendra virus and nipah virus
CA2837375C (en)	2011-06-01	2019-07-16	Merial Limited	Needle-free administration of prrsv vaccines
AU2012284097B2 (en)	2011-07-18	2017-08-03	President And Fellows Of Harvard College	Engineered microbe-targeting molecules and uses thereof
MX350096B (es)	2011-08-12	2017-08-25	Merial Inc	Preservación asistida con vacío de productos biológicos, en particular de vacunas.
WO2013093629A2 (en)	2011-12-20	2013-06-27	Netherlands Cancer Institute	Modular vaccines, methods and compositions related thereto
WO2013106558A1 (en)	2012-01-10	2013-07-18	Merial Limited	Lipid based adjuvants for dna - plasmid vaccines
EP3466443B1 (en)	2012-02-14	2020-12-16	Boehringer Ingelheim Animal Health USA Inc.	Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
SI2814508T1 (sl)	2012-02-14	2017-10-30	Merial, Inc.	Rotavirusna podenotska cepiva ter postopki njihove izdelave in uporaba
WO2013138776A1 (en)	2012-03-16	2013-09-19	Merial Limited	Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
EP2861248B1 (en)	2012-06-13	2017-11-15	Merial, Inc.	Reassortant btv and ahsv vaccines
KR102435054B1 (ko)	2012-08-01	2022-08-22	버베리안 노딕 에이/에스	재조합 변형된 백시니아 바이러스 앙카라(ankara) (mva) 호흡기 신시티알 바이러스(rsv) 백신
HK1216006A1 (zh)	2013-03-12	2016-10-07	Boehringer Ingelheim Animal Health USA Inc.	反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法
WO2014144325A1 (en)	2013-03-15	2014-09-18	President And Fellows Of Harvard College	Methods and compositions for improving detection and/or capture of a target entity
JP6649250B2 (ja)	2013-05-21	2020-02-19	プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ	操作されたヘム結合性構成物およびその使用
US10513546B2 (en)	2013-12-18	2019-12-24	President And Fellows Of Harvard College	CRP capture/detection of gram positive bacteria
WO2016073410A1 (en)	2014-11-03	2016-05-12	Merial, Inc.	Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
ES3050936T3 (en)	2015-06-23	2025-12-23	Boehringer Ingelheim Vetmedica Gmbh	Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
EP3331549B1 (en)	2015-08-06	2020-12-23	President and Fellows of Harvard College	Improved microbe-binding molecules and uses thereof
WO2017031120A1 (en)	2015-08-20	2017-02-23	Merial, Inc.	Fcv recombinant vaccines and uses thereof
HUE065661T2 (hu)	2015-09-29	2024-06-28	Boehringer Ingelheim Animal Health Usa Inc	Kutya parvovírus (CPV) vírusszerû részecske (VLP) vakcinák és alkalmazásuk
DK3380119T3 (da)	2015-11-23	2021-11-15	Boehringer Ingelheim Animal Health Usa Inc	Fmdv- og e2-fusionsproteiner og anvendelser deraf
TWI760322B (zh)	2016-01-29	2022-04-11	美商百靈佳殷格翰動物保健美國有限公司	重組腺病毒載體裝載之fmdv疫苗及其用途
CN109021081B (zh) *	2018-08-10	2019-06-04	山东大学	一种牛病毒性腹泻病毒样颗粒及其构建方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE105334T1 (de) *	1988-04-22	1994-05-15	Upjohn Co	Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
EP0540645A4 (en) *	1990-07-24	1993-12-29	The Uab Research Foundation	Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
GB9200117D0 (en) *	1992-01-06	1992-02-26	Connaught Lab	Production of recombinant chimeric proteins for vaccine use
CA2136677A1 (en) *	1993-12-29	1995-06-30	Intervet, Inc.	Method of intranasally administering to bovines a trivalent vaccine containing modified live ibrv, pl3v and brsv
ATE475668T1 (de) *	1994-01-27	2010-08-15	Univ Massachusetts Medical	Immunisierung durch impfung von dns transkriptionseinheit
US5541102A (en) *	1994-09-02	1996-07-30	Board Of Regents, University Of Nebraska-Lincoln	Bovine cell line resistant to in vitro infection by bovine viral diarrhea virus and all other known pestiviruses
US6019980A (en) *	1995-06-07	2000-02-01	Connaught Laboratories Limited	Nucleic acid respiratory syncytial virus vaccines
US6060457A (en)	1996-06-20	2000-05-09	Universite De Montreal	DNA plasmid vaccine for immunization of animals against BVDV
FR2751229B1 (fr) *	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
JP5566663B2 (ja) *	2009-11-09	2014-08-06	三菱重工業株式会社	多翼遠心ファンおよびそれを用いた空気調和機

1996
- 1996-07-19 FR FR9609403A patent/FR2751229B1/fr not_active Expired - Lifetime
1997
- 1997-07-06 NZ NZ508940A patent/NZ508940A/xx not_active IP Right Cessation
- 1997-07-06 NZ NZ517686A patent/NZ517686A/xx not_active IP Right Cessation
- 1997-07-06 NZ NZ508939A patent/NZ508939A/en not_active IP Right Cessation
- 1997-07-11 AR ARP970103111A patent/AR007862A1/es active IP Right Grant
- 1997-07-15 HR HR9609403A patent/HRP970383A2/hr not_active Application Discontinuation
- 1997-07-16 EP EP03016996A patent/EP1382348B1/fr not_active Expired - Lifetime
- 1997-07-16 AU AU37735/97A patent/AU734442B2/en not_active Expired
- 1997-07-16 PT PT97934578T patent/PT912194E/pt unknown
- 1997-07-16 CZ CZ20070776A patent/CZ298915B6/cs not_active IP Right Cessation
- 1997-07-16 DK DK03016996T patent/DK1382348T3/da active
- 1997-07-16 EP EP97934578A patent/EP0912194B1/fr not_active Expired - Lifetime
- 1997-07-16 UA UA99020960A patent/UA70914C2/uk unknown
- 1997-07-16 WO PCT/FR1997/001325 patent/WO1998003200A2/fr not_active Ceased
- 1997-07-16 CZ CZ0017599A patent/CZ298898B6/cs not_active IP Right Cessation
- 1997-07-16 DK DK97934578T patent/DK0912194T3/da active
- 1997-07-16 ZA ZA976283A patent/ZA976283B/xx unknown
- 1997-07-16 ES ES03016996T patent/ES2254833T3/es not_active Expired - Lifetime
- 1997-07-16 DE DE69734483T patent/DE69734483T2/de not_active Expired - Lifetime
- 1997-07-16 PL PL97331236A patent/PL190122B1/pl unknown
- 1997-07-16 ES ES97934578T patent/ES2210548T3/es not_active Expired - Lifetime
- 1997-07-16 AT AT97934578T patent/ATE253376T1/de active
- 1997-07-16 IL IL12770397A patent/IL127703A0/xx active IP Right Grant
- 1997-07-16 CA CA2260855A patent/CA2260855C/en not_active Expired - Lifetime
- 1997-07-16 BR BR9710506A patent/BR9710506A/pt not_active Application Discontinuation
- 1997-07-16 HU HU9902791A patent/HU225169B1/hu unknown
- 1997-07-16 HU HU0500910A patent/HU228353B1/hu unknown
- 1997-07-16 ID IDP972480A patent/ID19513A/id unknown
- 1997-07-16 JP JP09535655A patent/JP2000516200A/ja active Pending
- 1997-07-16 MA MA24716A patent/MA24269A1/fr unknown
- 1997-07-16 AT AT03016996T patent/ATE307607T1/de active
- 1997-07-16 DE DE69725988T patent/DE69725988T2/de not_active Expired - Lifetime
- 1997-07-16 NZ NZ333751A patent/NZ333751A/en not_active IP Right Cessation
- 1997-07-17 AP APAP/P/1997/001044A patent/AP9701044A0/en unknown
- 1997-07-18 PY PY199700970078A patent/PY970078A/es unknown
- 1997-07-18 CO CO97040983A patent/CO4700306A1/es unknown
1998
- 1998-01-16 PE PE1998000035A patent/PE84699A1/es not_active Application Discontinuation
- 1998-12-23 IL IL127703A patent/IL127703A/en not_active IP Right Cessation
1999
- 1999-01-15 US US09/232,279 patent/US6376473B1/en not_active Expired - Lifetime
2002
- 2002-02-28 US US10/085,519 patent/US6818628B2/en not_active Expired - Lifetime
- 2002-12-05 RU RU2002132831/13A patent/RU2305560C2/ru active

Also Published As

Publication number	Publication date
CA2260855C (en)	2012-01-03
HRP970383A2 (en)	1998-10-31
PT912194E (pt)	2004-03-31
AR007862A1 (es)	1999-11-24
NZ333751A (en)	2001-03-30
WO1998003200A3 (fr)	1998-02-26
US6376473B1 (en)	2002-04-23
US20020160018A1 (en)	2002-10-31
AP9701044A0 (en)	1997-07-31
IL127703A (en)	2006-12-31
FR2751229B1 (fr)	1998-11-27
BR9710506A (pt)	1999-08-17
UA70914C2 (uk)	2004-11-15
DE69725988D1 (de)	2003-12-11
HU228353B1 (en)	2013-03-28
ID19513A (id)	1998-07-16
CZ17599A3 (cs)	1999-06-16
HU225169B1 (en)	2006-07-28
PY970078A (es)	2001-12-03
ES2254833T3 (es)	2006-06-16
EP1382348A3 (fr)	2004-01-28
DK0912194T3 (da)	2004-03-15
RU2305560C2 (ru)	2007-09-10
ATE307607T1 (de)	2005-11-15
EP1382348A2 (fr)	2004-01-21
CA2260855A1 (en)	1998-01-29
PL331236A1 (en)	1999-07-05
JP2000516200A (ja)	2000-12-05
CZ298915B6 (cs)	2008-03-12
PL190122B1 (pl)	2005-11-30
ZA976283B (en)	1999-01-19
IL127703A0 (en)	1999-10-28
CZ298898B6 (cs)	2008-03-05
AU734442B2 (en)	2001-06-14
PE84699A1 (es)	1999-11-28
RU2002132831A (ru)	2005-01-20
ES2210548T3 (es)	2004-07-01
DE69725988T2 (de)	2004-11-11
AU3773597A (en)	1998-02-10
WO1998003200A2 (fr)	1998-01-29
MA24269A1 (fr)	1998-04-01
EP0912194B1 (fr)	2003-11-05
EP0912194A2 (fr)	1999-05-06
DE69734483T2 (de)	2006-07-20
ATE253376T1 (de)	2003-11-15
HU0500910D0 (en)	2005-11-28
EP1382348B1 (fr)	2005-10-26
NZ508940A (en)	2002-09-27
CO4700306A1 (es)	1998-12-29
DE69734483D1 (de)	2005-12-01
HUP9902791A2 (hu)	1999-12-28
US6818628B2 (en)	2004-11-16
NZ508939A (en)	2002-04-26
HUP9902791A3 (en)	2000-03-28
FR2751229A1 (fr)	1998-01-23
NZ517686A (en)	2003-01-31

Publication	Publication Date	Title
DK1382348T3 (da)	2006-03-13	Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom
DK0941103T3 (da)	2002-04-15	Farmaceutisk præparat til behandling af diabetes
DE69734778D1 (de)	2006-01-05	Polynukleotid-impfstoffformulierung gegen pferdekrankheiten
DK0797991T3 (da)	2004-04-05	Lægemiddelformulering med forhalet frigivelse
DK1093370T3 (da)	2006-05-22	Farmaceutisk præparat til behandling af diabetes
DZ2462A1 (fr)	2003-01-18	Vaccin antigrippal.
DK0912743T3 (da)	2006-01-30	Polynukleotidvaccinepræparat til behandling af luftvejs- og reproduktionssygdomme hos svin
ATE447947T1 (de)	2009-11-15	Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO996133D0 (no)	1999-12-10	Olje-i-vann-vaksinesammensetninger
DE69511950D1 (de)	1999-10-14	Entkuppelbares selbstblockierendes Abseilgerät
FI971732A7 (fi)	1997-06-23	Rokote ja antitoksiini C. difficilen aiheuttaman taudin hoitamiseksi j a estämiseksi
DE69730839D1 (de)	2004-10-28	Hühner polynukleotide impfstoff-formulierung
NO991815L (no)	1999-04-16	Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
FR2751223B1 (fr)	1998-12-04	Formule de vaccin polynucleotidique felin
EE9900469A (et)	2000-06-15	Sulfoonamiidid endoteliini vahendatud haiguste raviks
EE200300214A (et)	2003-08-15	Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
DZ2283A1 (fr)	2002-12-25	Composition de vaccin.
DK0979079T3 (da)	2004-10-25	Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
DE3776999D1 (de)	1992-04-09	Mittel zur vorbeugung gegen pflanzenviruskrankheiten.
BR9711225A (pt)	1999-08-17	Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
NO991459L (no)	1999-03-25	Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE60032884D1 (de)	2007-02-22	Blutbehandlungssystem
DE69737067D1 (de)	2007-01-18	Vakzine zur behandlung von mycosen
FI20070041L (fi)	2007-01-17	Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
BR9806083A (pt)	1999-08-24	Composi-Æo farmac-utica para o tratamento da hapattite c